Skip to main content

BIVIGAM

Generic: Immune Globulin Intravenous (Human) 10%

Data may be stale·Apr 23, 2026
NDC
69800-6502
RxCUI
1809414
Route
INTRAVENOUS
ICD-10 indication
D80.9

Affordability Check

How much will you actually pay for BIVIGAM?

In 30 seconds, see every legitimate way to afford BIVIGAM — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About BIVIGAM

Bivigam is an Immune Globulin Intravenous (Human) 10 percent liquid solution indicated for the treatment of primary humoral immunodeficiency (PI) in adults and adolescents (12 to 17 years of age). It provides a broad spectrum of IgG antibodies derived from healthy human plasma to help bolster the immune response and reduce the risk of serious infections. The medication is administered via intravenous infusion every three to four weeks to maintain adequate immunoglobulin levels.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How BIVIGAM appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-08-31).

Covered by plans

19%

1,021 of 5,499 plans

Most common tier

Tier 5

On 79% of covering formularies

Prior authorization required

100%

of covering formularies

TierFormularies on this tierShare
Tier 1 (preferred generic)16
17%
Tier 2 (generic)1
1%
Tier 3 (preferred brand)1
1%
Tier 4 (non-preferred brand)1
1%
Tier 5 (specialty)75
79%
Tier 61
1%

Step therapy: 0% of formularies

Quantity limits: 0% of formularies

Coverage breadth: 95 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

PayerPAStep therapyCopay tier

—

Medicare Part D

Yes——

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.